Back to search

Article

Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycemic control

2025-10-02

Abstract excerpt

Metformin is a therapeutically versatile biguanide drug primarily prescribed for type II diabetes. Despite its extensive use, the mechanisms underlying many of its clinical effects, including attenuated postprandial glucose excursions, elevated intestinal glucose uptake, and increased production of lactate, Lac-Phe and GDF15, remain unclear. Here, we map these and other clinical effects of metformin to intestine-s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c4c82571-faa3-5ca0-8959-929e180798b4
DOI
10.1101/2025.10.02.678294
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycemic controlDOI 10.1101/2025.10.02.678294
Select a neighboring publication to make it the new centre.